Integrated analysis of bulk transcriptomics and single-cell transcriptomics revealed the association characteristics between heart failure and β-hydroxybutyrylation-related genes
- 1Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region Nanning, China
- 2Guangxi University of Chinese Medicine Nanning, China
Abstract
Background: As a major cause of global mortality, heart failure (HF) has mechanisms that remain elusive. Recent studies suggest β-hydroxybutyrylation (Kbhb) may contribute to its pathogenesis, driving this investigation into Kbhb-associated HF biomarkers. Methods: We collected HF-associated data and information on Kbhb-related genes (KRGs) from publicly available databases and published studies. Potential biomarker candidates were identified by determining the overlap between differentially expressed genes (DEGs) and KRGs. Subsequently, machine learning algorithms, ROC curve evaluation, and expression verification were applied to identify robust biomarkers. To investigate the biological roles of these biomarkers in HF, we performed functional enrichment analysis, assessed the immune microenvironment, predicted regulatory networks and therapeutic compounds, and conducted molecular docking simulations. Furthermore, we utilized scRNA-seq data to determine critical cell populations and examine the expression patterns of biomarkers across different cellular contexts. Additionally, we used serum samples from four heart failure patients and four healthy controls to validate the protein expression levels of the identified biomarkers using enzyme-linked immunosorbent assay (ELISA). Results: Three genes—HMOX2, H2AFZ, and KPNA2—were determined as diagnostic biomarkers for HF. Functional enrichment analyses demonstrated that these biomarkers exhibited significant associations with essential biological pathways, such as proteasome-mediated processes, oxidative phosphorylation mechanisms, and amino acid metabolic pathways. Furthermore, neutrophil infiltration showed significant positive correlations with both H2AFZ (cor = 0.42, p < 0.05) and KPNA2 (cor = 0.39, p < 0.05). Moreover, regulatory factor SP1 was predicted to target both KPNA2 and HMOX2. Thereafter, molecular docking confirmed potent binding of Bisphenol A to all 3 biomarkers, especially to HMOX2 (binding energy = −7.3 kcal/mol). Interestingly, T cells were identified as the key cell type in HF, and biomarkers exhibited dynamic changes during their differentiation. ELISA verification further confirmed that protein levels of HMOX2(P< 0.05) and KPNA2(P< 0.05) were significantly downregulated in HF patients, consistent with bioinformatics predictions. By contrast, H2AFZ exhibited a decreasing trend but without statistical significance (p> 0.05). Conclusion: HMOX2 and KPNA2 were identified as Kbhb-related biomarkers in HF, while T cells served as a key cell type in the disease. Meanwhile, this study provided novel therapeutic targets for HF patients.
Related
- Forensic characteristics and genetic variations of Han Chinese population in Shenzhen revealed by 23 autosomal STRs
- Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging
- FITdb, an integrated Functional Immunogenomics and Transcriptomics database
- Synovial SLC1A5-Associated Amino Acid Metabolic Features in Knee Osteoarthritis: An Integrated Analysis of Synovial Transcriptomics, Fecal Metabolomics, and Gut Microbiota
- Identification of Toxicological Targets of Benzo[a]pyrene and Its Metabolite BPDE in Lung Adenocarcinoma Revealed by Integrated Network Toxicology, Machine Learning and Multi-Omics
BibTeX
@article{li2026integrated,
title = {{Integrated analysis of bulk transcriptomics and single-cell transcriptomics revealed the association characteristics between heart failure and β-hydroxybutyrylation-related genes}},
author = {Qingkuan Li and Xiyong Sheng and Guihua Li and Junjun Chen and Huayuan Zeng and Kaiyou Liu and Huating Huang and Yusheng Long and Zhihong Lu and Qingwei Ji},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0357103},
url = {https://doi.org/10.1371/journal.pone.0357103},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Integrated analysis of bulk transcriptomics and single-cell transcriptomics revealed the association characteristics between heart failure and β-hydroxybutyrylation-related genes
AU - Qingkuan Li
AU - Xiyong Sheng
AU - Guihua Li
AU - Junjun Chen
AU - Huayuan Zeng
AU - Kaiyou Liu
AU - Huating Huang
AU - Yusheng Long
AU - Zhihong Lu
AU - Qingwei Ji
PY - 2026
DA - 2026/09/18
JO - PLOS One
DO - 10.1371/journal.pone.0357103
UR - https://doi.org/10.1371/journal.pone.0357103
AB - Background: As a major cause of global mortality, heart failure (HF) has mechanisms that remain elusive. Recent studies suggest β-hydroxybutyrylation (Kbhb) may contribute to its pathogenesis, driving this investigation into Kbhb-associated HF biomarkers. Methods: We collected HF-associated data and information on Kbhb-related genes (KRGs) from publicly available databases and published studies. Potential biomarker candidates were identified by determining the overlap between differentially expressed genes (DEGs) and KRGs. Subsequently, machine learning algorithms, ROC curve evaluation, and expression verification were applied to identify robust biomarkers. To investigate the biological roles of these biomarkers in HF, we performed functional enrichment analysis, assessed the immune microenvironment, predicted regulatory networks and therapeutic compounds, and conducted molecular docking simulations. Furthermore, we utilized scRNA-seq data to determine critical cell populations and examine the expression patterns of biomarkers across different cellular contexts. Additionally, we used serum samples from four heart failure patients and four healthy controls to validate the protein expression levels of the identified biomarkers using enzyme-linked immunosorbent assay (ELISA). Results: Three genes—HMOX2, H2AFZ, and KPNA2—were determined as diagnostic biomarkers for HF. Functional enrichment analyses demonstrated that these biomarkers exhibited significant associations with essential biological pathways, such as proteasome-mediated processes, oxidative phosphorylation mechanisms, and amino acid metabolic pathways. Furthermore, neutrophil infiltration showed significant positive correlations with both H2AFZ (cor = 0.42, p < 0.05) and KPNA2 (cor = 0.39, p < 0.05). Moreover, regulatory factor SP1 was predicted to target both KPNA2 and HMOX2. Thereafter, molecular docking confirmed potent binding of Bisphenol A to all 3 biomarkers, especially to HMOX2 (binding energy = −7.3 kcal/mol). Interestingly, T cells were identified as the key cell type in HF, and biomarkers exhibited dynamic changes during their differentiation. ELISA verification further confirmed that protein levels of HMOX2(P< 0.05) and KPNA2(P< 0.05) were significantly downregulated in HF patients, consistent with bioinformatics predictions. By contrast, H2AFZ exhibited a decreasing trend but without statistical significance (p> 0.05). Conclusion: HMOX2 and KPNA2 were identified as Kbhb-related biomarkers in HF, while T cells served as a key cell type in the disease. Meanwhile, this study provided novel therapeutic targets for HF patients.
SN - 1932-6203
ER -